Uchida Yuichiro, Furuyama Hiroaki, Yasukawa Daiki, Nishino Hiroto, Ando Yasuhisa, Hata Toshiyuki, Machimoto Takafumi, Yoshimura Tsunehiro
Department of Gastrointestinal and General Surgery, Tenri Yorozu Hospital, 200 Mishima-cho, Tenri, Nara 632-8552, Japan.
Division of Hepato-Biliary-Pancreatic and Transplant Surgery, Graduate School of Medicine, Kyoto University, 54 Shogoin-kawahara-cho, Kyoto 606-8507, Japan.
HPB Surg. 2016;2016:7637838. doi: 10.1155/2016/7637838. Epub 2016 Jun 23.
Background. Hepatectomy, an important treatment modality for liver malignancies, has high perioperative morbidity and mortality rates. Safe, comprehensive criteria for selecting patients for hepatectomy are needed. Since June 2011, we have used a cut-off value of ≧ 0.05 for future liver remnant plasma clearance rate of indocyanine green as a criterion for hepatectomy. The aim of this study was to verify the validity of this criterion. Methods. From June 2011 to December 2015, 212 hepatectomies were performed in Tenri Yorozu Hospital. Of these 212 patients, 107 who underwent preoperative computed tomography imaging volumetry, indocyanine green clearance test, and hepatectomy (excluding partial resection or enucleation) were retrospectively analyzed. Results. There was no postoperative mortality. Posthepatectomy liver failure occurred in 59 patients (55.1%) (International Study Group of Liver Surgery Grade A: 43 cases (40.2%), Grade B: 16 cases (15.0%), and Grade C: no cases). Operative morbidity greater than Clavien-Dindo Grade 3 occurred in 23 patients (21.5%). A low future liver remnant plasma clearance rate of indocyanine green was a good predictor for Grade B cases (area under curve = 0.804; 95% confidence interval, 0.712-0.895). Conclusion. Liver remnant plasma clearance rate of indocyanine green is a valid criterion for hepatectomy.
背景。肝切除术是治疗肝脏恶性肿瘤的重要手段,但围手术期发病率和死亡率较高。因此,需要安全、全面的肝切除术患者选择标准。自2011年6月以来,我们将吲哚菁绿未来肝残余血浆清除率≥0.05作为肝切除术的标准。本研究旨在验证该标准的有效性。方法。2011年6月至2015年12月,天理八洲医院共进行了212例肝切除术。对其中107例行术前计算机断层扫描成像容积测量、吲哚菁绿清除试验及肝切除术(不包括部分切除或剜除术)的患者进行回顾性分析。结果。无术后死亡病例。59例患者(55.1%)发生肝切除术后肝功能衰竭(国际肝脏手术研究组A级:43例(40.2%),B级:16例(15.0%),C级:无病例)。23例患者(21.5%)发生大于Clavien-Dindo 3级的手术并发症。吲哚菁绿未来肝残余血浆清除率低是B级病例的良好预测指标(曲线下面积=0.804;95%置信区间,0.712 - 0.895)。结论。吲哚菁绿肝残余血浆清除率是肝切除术的有效标准。